Antibody-CD20-interferon-alpha fusion protein has superior in vivo activity against human B cell lymphomas compared to Rituximab, and enhanced complement-dependent cytotoxicity in vitro

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Yamada, Reiko, Steward, Kristopher, Ngarmchamnanrith, Gataree, Trinh, Ryan, Khare, Sanjay, Sachdev, Raj, Grewal, Iqbal, Morrison, Sherie, Timmerman, John
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Poster Presentation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3991073/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-1-S1-P263
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki